Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
This activity is supported by an unrestricted educational grant from Ipsen and Novartis Pharmaceuticals Corporation
Collaborative Practice in the Management of Patients With Gastrointestinal and Pancreatic Neuroendocrine Tumors
Jennifer Ang Chan, MD, MPH,
Dana-Farber Cancer Institute
Robin Sommers, DNP, ANP-BC, AOCNP
Dana-Farber Cancer Institute
Pancreatic neuroendocrine tumors have unique characteristics and are often unpredictable in their behavior, which necessitates a collaborative approach in diagnosis, treatment, and follow-up. This activity provides valuable information and updates, while highlighting the role of the AP as a vital part of the collaborative team in the overall management of this challenging patient population.
These CME/CE/CPE accredited activities are jointly provided by
